Navigation Links
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Date:10/22/2007

s dissolvable sutures. As with a metallic stent, Abbott's bioabsorbable stent is designed to restore blood flow by propping a clogged vessel open, and to provide support until the blood vessel heals. Unlike a metallic stent, however, a bioabsorbable stent is designed to be slowly metabolized by the body and completely absorbed over time.

As reported in March 2007, late loss, a measure of reduction in lumen (vessel) diameter after stenting, was 0.44 mm for ABSORB at six months.

"ABSORB is an exciting future generation device that has the potential to advance the treatment of coronary artery disease beyond the benefits that next-generation metallic drug eluting stent platforms can provide," said John M. Capek, PhD., executive vice president, Medical Devices, Abbott. "Positive data with Abbott's bioabsorbable technology is encouraging and supports the direction we are moving toward in helping physicians open blocked arteries with stents, while also allowing the stent itself to disappear over time."

About the ABSORB Clinical Trial

The ABSORB trial is a prospective, non-randomized (open label) study designed to enroll up to 60 patients in Belgium, Denmark, France, New Zealand, Poland and The Netherlands. Key endpoints of the study include assessments of safety -- MACE (defined as any event that resulted in re-treatment of a diseased artery, heart attack or cardiac death) and stent thrombosis (blood clot formation) rates -- at 30,180 and 270 days, with additional annual follow-up for up to five years, as well as an assessment of the acute performance of the bioabsorbable drug-eluting stent. Other key endpoints of the study include successful deployment of the bioabsorbable drug eluting stent, follow-up measurements assessed by angiography, intravascular ultrasound (IVUS), and state-of-the-art imaging modalities at 180 days and two years.

For images of Abbott's bioabsorbable stent and other information, please visit the company's online TCT ne
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015  Dynatronics Corporation (NASDAQ: DYNT ) ... First Annual Ladenburg Thalmann Healthcare Conference at the ... H. Cullimore, Jr. , Chairman and President, is ... on Tuesday, September 29 at 10:30 a.m. EDT.  ... showcase leading-edge companies in the healthcare arena. Mr. ...
(Date:9/1/2015)... Sept. 1, 2015 Konica Minolta Medical Imaging ... (CR) system, designed to deliver enterprise level imaging to ... same Control Station as the Konica Minolta AeroDR wireless ... upgrade path from CR to DR. The SIGMA II ... improve workflow with unparalleled reliability and high capacity to ...
(Date:9/1/2015)... , Sept. 1, 2015 Emerus Holdings, ... of emergent, inpatient and diagnostic care in partnership ... signed a definitive agreement to receive a strategic ... Carson), a leading health care investment firm. ... high-quality, patient-centric acute episodic and ambulatory clinical services ...
Breaking Medicine Technology:Konica Minolta Launches New CR System with Low-Cost Upgrade Path to DR 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
...  ERT (Nasdaq: ERT ), announced today that ... is scheduled to present at the Citi 2012 Global ... 2012 in New York. Interested parties may ... at http://www.ert.com . The webcast may also be ...
... a leading developer of stereotactic radiosurgery and cancer ... CyberKnife cancer center, which will begin treating patients ... through a partnership between Accelitech, physicians and Swedish ... Chicago will provide state-of-the-art CyberKnife treatment to patients ...
Cached Medicine Technology:ERT to Present at the Citi 2012 Global Health Care Conference February 29, 2012 2Accelitech to Open the First CyberKnife Cancer Center Within the City of Chicago 2
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit Inc., a leading supplier ... FirstSpirit Content Management System with new capabilities and enhancements designed to support the ... will be well on their way to achieving digital transformation with less time ...
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data loss ... version of endpoint DLP developed specifically for Mac OS. , In June 2015, the ... IT and information security professionals had participated. The beta test done by the developer ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based charity ... (FSHD), will be the beneficiary of a collection of fundraising events this fall. From ... of the FSH Society and further FSHD research. , The list of ...
(Date:9/1/2015)... ... 2015 , ... Agriculture innovation, urban farming, local food access, and sourcing from ... at Seedstock’s 4th Annual Sustainable Agriculture Conference : “Innovation and the Rise of ... addition to keynotes Pierre Sleiman, founder and CEO of Go Green Agriculture, and Daron ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed ... on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, ...
Breaking Medicine News(10 mins):Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:Zecurion Announces Endpoint Security for Mac 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2
... everyday products such as bicycle frames and hockey sticks could ... Certain types of carbon nanotubes cylindrical molecules about one-thousandth ... cancer in the lining of the lung, University of Edinburgh ... while short carbon nanotubes appeared relatively harmless if they entered ...
... Fox Chase Cancer Center, one of the nation,s leading ... entered into an agreement with Life Technologies Corporation that ... analysis of solid tumors. The agreement is a ... Fox Chase, a facility that will foster new discoveries ...
... Sleep duration has a significant association with feelings ... body among adolescent girls, especially those who are white, ... June 14, in Minneapolis, Minn., at SLEEP 2011, the ... LLC (APSS). Results show that pressures to have ...
... By John Leighty HealthDay Reporter , ... fall asleep, that tends to trigger marital tensions the ... issues of husbands barely impact spousal relationships. Researchers ... married couples for 10 nights using noninvasive sensors that ...
... 2011 A new study reports that colonoscopies ... relatively high adenoma (precancerous polyp) miss rates, suggesting ... and may mandate an early follow-up examination. In ... preparation, of all adenomas identified, 42 percent were ...
... of stem cells A team of researchers, ... Biological Studies, La Jolla, has generated data in mice that ... the smell-sensing region of the human nose (human olfactory ectomesenchymal ... treat brain disorders in which nerve cells are lost or ...
Cached Medicine News:Health News:Fox Chase Cancer Center signs agreement with Life Technologies Corp. 2Health News:Fox Chase Cancer Center signs agreement with Life Technologies Corp. 3Health News:White adolescent girls may be losing sleep from the pressure to be thin 2Health News:When Wives Can't Sleep, Marriage May Suffer 2Health News:When Wives Can't Sleep, Marriage May Suffer 3Health News:Polyp miss rates high for colonoscopies done after poor bowel preparation 2Health News:Polyp miss rates high for colonoscopies done after poor bowel preparation 3Health News:Polyp miss rates high for colonoscopies done after poor bowel preparation 4Health News:JCI online early table of contents: June 13, 2011 2Health News:JCI online early table of contents: June 13, 2011 3Health News:JCI online early table of contents: June 13, 2011 4Health News:JCI online early table of contents: June 13, 2011 5Health News:JCI online early table of contents: June 13, 2011 6Health News:JCI online early table of contents: June 13, 2011 7Health News:JCI online early table of contents: June 13, 2011 8Health News:JCI online early table of contents: June 13, 2011 9Health News:JCI online early table of contents: June 13, 2011 10
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: